511 related articles for article (PubMed ID: 29842979)
1. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
[TBL] [Abstract][Full Text] [Related]
2. Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Tadele G; Jawara A; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L
Malar J; 2023 Jun; 22(1):171. PubMed ID: 37270589
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
[TBL] [Abstract][Full Text] [Related]
5. Molecular Evidence for
Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
[TBL] [Abstract][Full Text] [Related]
6. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B
Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781
[TBL] [Abstract][Full Text] [Related]
7. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
8. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP
PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014
[TBL] [Abstract][Full Text] [Related]
9. Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy.
Mohapatra PK; Sarma DK; Prakash A; Bora K; Ahmed MA; Sarma B; Goswami BK; Bhattacharyya DR; Mahanta J
PLoS One; 2014; 9(9):e105562. PubMed ID: 25184337
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy.
Lobo E; de Sousa B; Rosa S; Figueiredo P; Lobo L; Pateira S; Fernandes N; Nogueira F
Malar J; 2014 Aug; 13():300. PubMed ID: 25098280
[TBL] [Abstract][Full Text] [Related]
11. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
Bakari C; Mandara CI; Madebe RA; Seth MD; Ngasala B; Kamugisha E; Ahmed M; Francis F; Bushukatale S; Chiduo M; Makene T; Kabanywanyi AM; Mahende MK; Kavishe RA; Muro F; Mkude S; Mandike R; Molteni F; Chacky F; Bishanga DR; Njau RJA; Warsame M; Kabula B; Nyinondi SS; Lucchi NW; Talundzic E; Venkatesan M; Moriarty LF; Serbantez N; Kitojo C; Reaves EJ; Halsey ES; Mohamed A; Udhayakumar V; Ishengoma DS
Malar J; 2024 Mar; 23(1):71. PubMed ID: 38461239
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
[TBL] [Abstract][Full Text] [Related]
13. Sustained
Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
[TBL] [Abstract][Full Text] [Related]
14. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Dlamini SV; Beshir K; Sutherland CJ
Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
[TBL] [Abstract][Full Text] [Related]
15. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
[TBL] [Abstract][Full Text] [Related]
16. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
[TBL] [Abstract][Full Text] [Related]
17. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.
Mbaye A; Dieye B; Ndiaye YD; Bei AK; Muna A; Deme AB; Yade MS; Diongue K; Gaye A; Ndiaye IM; Ndiaye T; Sy M; Diallo MA; Badiane AS; Ndiaye M; Seck MC; Sy N; Koita O; Krogstad DJ; Nwakanma D; Ndiaye D
Malar J; 2016 Aug; 15(1):433. PubMed ID: 27562216
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia.
Hassen J; Alemayehu GS; Dinka H; Golassa L
Malar J; 2022 Oct; 21(1):286. PubMed ID: 36207750
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]